Skip to Main Content

Paper Details

Design and optimisation of dendrimer-conjugated Bcl-2/x<sub>L</sub> inhibitor, AZD0466, with improved therapeutic index for cancer therapy.
Commun Biol
51
2021
Author NameAffiliation
William McCoullOncology R&D
Francis D GibbonsOncology R&D
Edward J HennessyOncology R&D
J Paul SecristOncology R&D
Alwin G SchullerOncology R&D
Shenghua WenOncology R&D
Ammar AdamOncology R&D
Justin CidadoOncology R&D
Martin WildOncology R&D
Eric GanglOncology R&D
Stephen FawellOncology R&D
Jamal C SaehOncology R&D
Barry R DaviesOncology R&D
  • 1 - 13

Datasets

Release 1.2